Neurocrine Biosciences
NBIX
NBIX
207 hedge funds and large institutions have $3.29B invested in Neurocrine Biosciences in 2015 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 81 increasing their positions, 78 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
17% less capital invested
Capital invested by funds: $3.98B → $3.29B (-$691M)
Holders
207
Holding in Top 10
4
Calls
$65M
Puts
$28.8M
Top Buyers
| 1 | +$72.4M | |
| 2 | +$18.4M | |
| 3 | +$18M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.9M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$10.3M |
Top Sellers
| 1 | -$67.5M | |
| 2 | -$50.9M | |
| 3 | -$40.7M | |
| 4 |
Axa
Paris,
France
|
-$13.8M |
| 5 |
PA
Perceptive Advisors
New York
|
-$13.6M |